Journal Title：Science Translational Medicine

Science Translational Medicine Mission: To promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners and trainees from all relevant established and emerging disciplines.

Scope: Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.

科學轉化醫(yī)學使命：通過為所有相關既有和新興學科的基礎、轉化和臨床研究從業(yè)者和受訓人員提供一個交流和相互借鑒的論壇，促進人類健康。

范圍：心血管疾病、免疫學/疫苗、代謝/糖尿病/肥胖癥、神經(jīng)科學/神經(jīng)病學/精神病學、癌癥、傳染病、政策、行為、生物工程、化學基因組學/藥物發(fā)現(xiàn)、成像、應用物理科學、醫(yī)學納米技術、藥物輸送、生物標志物、基因治療/再生醫(yī)學、毒理學和藥代動力學、數(shù)據(jù)挖掘、細胞培養(yǎng)、動物和人體研究、醫(yī)學信息學和其他跨學科醫(yī)學方法。

Science Translational Medicine創(chuàng)刊于2009年，由American Association for the Advancement of Science出版商出版，收稿方向涵蓋MEDICINE, RESEARCH & EXPERIMENTAL - CELL BIOLOGY全領域，在行業(yè)領域中學術影響力很大，屬于TOP期刊，國際一流期刊，關注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于TOP期刊，建議關注此刊。平均審稿速度 約1.0個月 ，影響因子指數(shù)15.8，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。